Completed A Safety Study for Previously Treated Vatiquinone (PTC743) Participants With Inherited Mitochondrial Disease NCT05218655 Conditions Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Brain Diseases, +36 more Locations University of California, San Diego Altman Clinical and Translational Research Institute — La Jolla, California, United States Stanford University — Stanford, California, United States Yale Medicine — New Haven, Connecticut, United States Children's National — Washington D.C., District of Columbia, United States View all 26 locations View more locations Show fewer locations Loading locations... View Trial Details
Completed Safety, Tolerability, Efficacy and Optimal Dose Finding Study of BAF312 in Patients With Relapsing-remitting Multiple Sclerosis NCT00879658 Conditions Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Brain Diseases, +16 more Locations Novartis Investigative Site — Cullman, Alabama, United States Novartis Investigative Site — San Francisco, California, United States Novartis Investigative Site — Centennial, Colorado, United States Novartis Investigative Site — Miami, Florida, United States View all 72 locations View more locations Show fewer locations Loading locations... View Trial Details
